Completed Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ)
|Key Fields||Japan Genomic Medicine Program(1st)|
|R&D phase||Basic Study|
This project involves the use of disease biobank functions and genome data analysis functions to identify and verify the mechanism of onset of diseases as well as responsiveness to therapeutic drugs and side effects, and also promotes research that contributes to diagnosis and treatment utilizing genetic data, with the aim of enabling the practical implementation of individually optimized medical treatment (tailor-made medicine).
Here is more on BioBank Japan.
Management and Evaluation Framework
- Dr. Shinichi Kohsaka (Director-General Emeritus, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
- Dr. Shumpei Ishikawa (Professor, Medical Research Institute, Tokyo Medical and Dental University)
Dr. Hidewaki Nakagawa (Team Leader, RIKEN Center for Integrative Medical Sciences)
Last updated 04/10/17